Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 27 Feb 2006):

Clinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery.

Full Abstract

BACKGROUND:
A reduction in postoperative length of stay (PLOS) was recently demonstrated with the use of leukoreduced (LR) blood in cardiac surgery patients compared to a historical cohort who received non-LR blood. Follow-up data are now presented in a similar population after a 12-month period in which LR blood was no longer routinely used.

STUDY DESIGN AND METHODS:
This is an extension of a study in which all patients admitted over a 12-month period for open heart surgery were given LR blood (Group 2) and were compared against a historical cohort given non-LR blood (Group 1). This study measures the outcomes of a new cohort of patients admitted during a 12-month period where LR blood was no longer routinely used (Group 3).

RESULTS:
PLOS increased in patients who received transfusions with non-LR blood (Group 3, n = 595) versus patients with LR blood (Group 2, n = 645; p = 0.045 by nonparametric rank U test). Mean PLOS increased from 9.5 days (95% confidence interval [CI], 8.9-10.0) to 10.8 days (95% CI, 10.0-11.6). In comparison, an earlier cohort who received non-LR blood (Group 1, n = 501) had a mean PLOS of 10.1 days (95% CI, 9.4-10.7). With the exception of decreased red blood cell (RBC) usage in Group 3, there were no significant differences in non-RBC blood usage, estimated blood loss, bypass time, mediastinitis rates, operative mortality rate, or overall mix of cases.

CONCLUSIONS:
The use of non-LR blood for cardiac surgery was associated with an increased PLOS compared to the use of LR blood and supports our previous demonstration of the benefits of LR blood in cardiac surgery.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Fung, Mark K (MK); Moore, Karan (K); Ridenour, Marilyn (M); Mook, William (W); Triulzi, Darrell J (DJ);

Affiliation: Department of Pathology, University of Vermont, Burlington, VT, USA. Mark.Fung(-atsign-)vtmednet.org

Journal and publication information

Publication Type: Comparative Study; Journal Article

Journal: Transfusion (Transfusion), published in United States. (Language: eng)

Reference: 2006-Mar; vol 46 (issue 3) : pp 386-91

Dates: Created 2006/03/14; Completed 2006/04/20; Revised 2006/11/15;

PMID: 16533280, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

5/15/2004
8/30/2006
Higher Relevance Score (8)
Lower Relevance Score (7)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index